Heikkinen, T., Valkonen, H., Lehtonen, L., Vainionpaa, R., & Ruuskanen, O. (2005). Hospital admission of high risk infants for respiratory syncytial virus infection: Implications for palivizumab prophylaxis. BMJ Group.
Chicago-стиль цитированияHeikkinen, T., H. Valkonen, L. Lehtonen, R. Vainionpaa, and O. Ruuskanen. Hospital Admission of High Risk Infants for Respiratory Syncytial Virus Infection: Implications for Palivizumab Prophylaxis. BMJ Group, 2005.
MLA-цитированиеHeikkinen, T., et al. Hospital Admission of High Risk Infants for Respiratory Syncytial Virus Infection: Implications for Palivizumab Prophylaxis. BMJ Group, 2005.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.